Pub Date : 2020-03-01DOI: 10.21019/9781582123332.immunizations
Skin infections in high school athletes pose a risk of transmission to other student athletes. Therefore, it is important to promptly identify possible skin infections and refer them to the healthcare provider for treatment so athletes can return to play quickly and with little interruption to the team. Common skin infections include bacterial infections such as Streptococcus and Staphylococcus, viral infections such as herpes simplex and molluscum contagiosum, and fungal infections such as tinea corporis and capitis. The National Federation of State High School Associations provides guidance for the prevention of skin infections as well as return to play guidelines. The school nurse and high school athletic trainer are both healthcare professionals who play a role in preventing, identifying, monitoring, and caring for student athletes who contract skin infections.
{"title":"Immunizations","authors":"","doi":"10.21019/9781582123332.immunizations","DOIUrl":"https://doi.org/10.21019/9781582123332.immunizations","url":null,"abstract":"Skin infections in high school athletes pose a risk of transmission to other student athletes. Therefore, it is important to promptly identify possible skin infections and refer them to the healthcare provider for treatment so athletes can return to play quickly and with little interruption to the team. Common skin infections include bacterial infections such as Streptococcus and Staphylococcus, viral infections such as herpes simplex and molluscum contagiosum, and fungal infections such as tinea corporis and capitis. The National Federation of State High School Associations provides guidance for the prevention of skin infections as well as return to play guidelines. The school nurse and high school athletic trainer are both healthcare professionals who play a role in preventing, identifying, monitoring, and caring for student athletes who contract skin infections.","PeriodicalId":340620,"journal":{"name":"Peripheral Brain for the Pharmacist, 2021-2022","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134496842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-03-01DOI: 10.21019/9781582123332.specialpopulations
{"title":"Special Populations","authors":"","doi":"10.21019/9781582123332.specialpopulations","DOIUrl":"https://doi.org/10.21019/9781582123332.specialpopulations","url":null,"abstract":"","PeriodicalId":340620,"journal":{"name":"Peripheral Brain for the Pharmacist, 2021-2022","volume":"5 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141226349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: The TMPRSS2 protein is an entry pathway for SARS-CoV-2, its expression is up-regulated by testosterone. Men have 7 to 8 times higher serum testosterone than women. We propose that patients hospitalized with COVID-19, with higher levels of testosterone, have worse outcomes than those with lower levels. Methods: A prospective, observational analysis of patients over 18-years-old with COVID-19 admitted to the internal medicine department in Mexicali’s General Hospital from January to April 2021. Results: 49 patients included, 32 men with a mean free testosterone of 2.95 pg/ml; 17 women with a mean of 1.08 pg/ml (p = 0.0002). 16 patients survived, with a mean of 3.21 pg/ml while 33 patients died with a mean of 1.82 pg/ ml (p = 0.007). In the male subgroup, the mean of survivors was 3.95 pg/m, in non-survivors was 2.43 pg/ml (p = 0.017). In women, the survivors mean was 1.85 pg/ml while in non-survivors it was 0.66 pg/ml (p = 0.01). Conclusions: Our study showed that hospitalized patients with COVID-19, with lower levels of free testosterone have worse outcomes than those with higher levels.
{"title":"Respiratory","authors":"Jesús Alan, MD Guardado Vindiola, Gisela Viviana, MD Licon Martinez, Marina Estrada-Rodriguez, Katya Lorena Wilhelmy-Ledesma, Joaquin Córdova Erberk, Álvaro Lozano Castañeda, MD MSc Miguel Angel Gaxiola-García, MD Hiram Javier Jaramillo-Ramírez","doi":"10.32388/w5ppdp","DOIUrl":"https://doi.org/10.32388/w5ppdp","url":null,"abstract":"Background: The TMPRSS2 protein is an entry pathway for SARS-CoV-2, its expression is up-regulated by testosterone. Men have 7 to 8 times higher serum testosterone than women. We propose that patients hospitalized with COVID-19, with higher levels of testosterone, have worse outcomes than those with lower levels. Methods: A prospective, observational analysis of patients over 18-years-old with COVID-19 admitted to the internal medicine department in Mexicali’s General Hospital from January to April 2021. Results: 49 patients included, 32 men with a mean free testosterone of 2.95 pg/ml; 17 women with a mean of 1.08 pg/ml (p = 0.0002). 16 patients survived, with a mean of 3.21 pg/ml while 33 patients died with a mean of 1.82 pg/ ml (p = 0.007). In the male subgroup, the mean of survivors was 3.95 pg/m, in non-survivors was 2.43 pg/ml (p = 0.017). In women, the survivors mean was 1.85 pg/ml while in non-survivors it was 0.66 pg/ml (p = 0.01). Conclusions: Our study showed that hospitalized patients with COVID-19, with lower levels of free testosterone have worse outcomes than those with higher levels.","PeriodicalId":340620,"journal":{"name":"Peripheral Brain for the Pharmacist, 2021-2022","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123950353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-03-01DOI: 10.21019/9781582123158.counselingstandardscare
{"title":"Counseling and Standards of Care","authors":"","doi":"10.21019/9781582123158.counselingstandardscare","DOIUrl":"https://doi.org/10.21019/9781582123158.counselingstandardscare","url":null,"abstract":"","PeriodicalId":340620,"journal":{"name":"Peripheral Brain for the Pharmacist, 2021-2022","volume":"37 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121173566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-03-01DOI: 10.21019/9781582123158.specificdiseasestatemanagement
{"title":"Specific Disease State Management","authors":"","doi":"10.21019/9781582123158.specificdiseasestatemanagement","DOIUrl":"https://doi.org/10.21019/9781582123158.specificdiseasestatemanagement","url":null,"abstract":"","PeriodicalId":340620,"journal":{"name":"Peripheral Brain for the Pharmacist, 2021-2022","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129486180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.21019/9781582123707.calc
{"title":"Calculations/Conversions/General Monitoring","authors":"","doi":"10.21019/9781582123707.calc","DOIUrl":"https://doi.org/10.21019/9781582123707.calc","url":null,"abstract":"","PeriodicalId":340620,"journal":{"name":"Peripheral Brain for the Pharmacist, 2021-2022","volume":"62 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130002429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：